Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | LOTUSEYE Lotus Eye Hospital and Institute Limited Pharma · Small | MEDICO Medico Remedies Limited Pharma · Small | ZIMLAB Zim Laboratories Limited Pharma · Small | LYKALABS Lyka Labs Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 13 | 52 | 21 | 22 |
| Verdict | OVERVALUED | FAIR VALUE | OVERVALUED | OVERVALUED |
| Style | OVERVALUED | Financial Turnaround | OVERVALUED | OVERVALUED |
| Piotroski | 6/9 | 8/9 | 6/9 | 6/9 |
| Valuation | 1/30 | 8/30 | 4/30 | 5/30 |
| Growth | 4/25 | 14/25 | 3/25 | 6/25 |
| Quality | 0/20 | 14/20 | 0/20 | 0/20 |
| Balance Sheet | 4/15 | 10/15 | 7/15 | 7/15 |
| Cash Flow | 4/10 | 4/10 | 4/10 | 4/10 |
| Price | ₹122.39 | ₹43.42 | ₹113.05 | ₹70.05 |
| P/E | 3065.00 | 27.60 | 133.00 | — |
| P/B | 4.08 | 4.80 | 1.95 | 2.46 |
| ROE | 0.13% | 19.00% | 1.59% | -10.20% |
| ROCE | 1.16% | 23.10% | 4.76% | -6.10% |
| Debt / Equity | 0.26 | 0.25 | 0.43 | 0.53 |
| FCF Yield | — | 0.28% | — | — |
| Dividend Y | — | — | — | — |
| Altman Z | 7.71 | 5.25 | 3.14 | 2.96 |
| Promoter % | 40.14% | 61.38% | 30.35% | 58.16% |
| Mkt Cap (₹Cr) | 245.00 | 362.00 | 577.00 | 227.00 |
| Graham # | ₹5.1 | ₹17.99 | ₹36.86 | — |
| Fair PE | 1.0 | 42.0 | 2.8 | 8.7 |
| MoS % | -308965.7% | +34.6% | -3604.3% | — |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startLOTUSEYE183
MEDICO75
ZIMLAB99
LYKALABS47